Articles dans des revues avec comité de lecture (257)

  1. 71. Remmelink, M., de Leval, L., Decaestecker, C., Duray, A., Crompot, E., Sirtaine, N., André, S., Kaltner, H., Leroy, X., Gabius, H.-J., & Saussez, S. (2011). Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential. Histopathology, 58(4), 543-556. doi:10.1111/j.1365-2559.2011.03776.x
  2. 72. Ernoux-Neufcoeur, P., Arafa, M., Decaestecker, C., Duray, A., Remmelink, M., Leroy, X., Herfs, M., Somja, J., Depuydt, C. E., Delvenne, P. O., & Saussez, S. (2011). Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. Journal of cancer research and clinical oncology, 137(1), 173-181. doi:10.1007/s00432-010-0871-2
  3. 73. Rorive, S., Moles Lopez, X., Maris, C., Trepant, A.-L., Sauvage, S., Sadeghi-Meibodi, N., Roland, I., Decaestecker, C., & Salmon, I. (2010). TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. Modern pathology, 23(10), 1418-1428. doi:10.1038/modpathol.2010.136
  4. 74. Cludts, S., Decaestecker, C., Johnson, B., Lechien, J., Leroy, X., Kindt, N., Kaltner, H., André, S., Gabius, H.-J., & Saussez, S. (2010). Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. Anticancer research, 30(9), 3313-3319.
  5. 75. Le Calve, B., Rynkowski, M., Le Mercier, M., Bruyère, C., Lonez, C., Gras, T., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J. M., Kiss, R., & Lefranc, F. (2010). Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (New York, N.Y.), 12(9), 727-739. doi:10.1593/neo.10526
  6. 76. Balde, E. S., Megalizzi, V., Traoré, M. S., Cos, P., Maes, L., Decaestecker, C., Pieters, L., & Balde, A. (2010). In vitro antiprotozoal, antimicrobial and antitumor activity of Pavetta crassipes K. Schum leaf extracts. Journal of ethnopharmacology, 130(3), 529-535. doi:10.1016/j.jep.2010.05.042
  7. 77. Rorive, S., D'Haene, N., Fossion, C., Delpierre, I., Abarguia, N., Avni, E., Decaestecker, C., & Salmon, I. (2010). Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. European journal of endocrinology, 162(6), 1107-1115. doi:10.1530/EJE-09-1103
  8. 78. Saussez, S., de Leval, L., Decaestecker, C., Sirtaine, N., Cludts, S., Duray, A., Chevalier, D., André, S., Gabius, H.-J., Remmelink, M., & Leroy, X. (2010). Galectin fingerprinting in Warthin's tumors: lectin-based approach to trace its origin? Histology and histopathology, 25(5), 541-550.
  9. 79. Mancilla, V., Decaestecker, C., Ligny, C., Matagne, L., Simon, P., & Courtmans, I. (2010). La surdité moyenne: Étiologie, évaluation linguistique et scolaire. Cahiers de l'audition, 23(3), 5-9.
  10. 80. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  11. 81. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  12. 82. Lamoral-Theys, D., Decaestecker, C., Mathieu, V., Dubois, J., Kornienko, A., Kiss, R., Evidente, A., & Pottier, L. (2010). Lycorine and its derivatives for anticancer drug design. Mini-reviews in medical chemistry, 10(1), 41-50. doi:10.2174/138955710791112604

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>